Company / Revenue
Processa Pharmaceuticals, Inc. Revenue History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2022
5-year range
$0 / $312.5K
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $113,425 to $0 over the past 6 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2016 | $113.4K | +5.8% |
| FY2015 | $107.2K | -65.7% |
| FY2014 | $312.5K | +62.6% |
| FY2013 | $192.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026